Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
263 studies found for:    microspheres
Show Display Options
Rank Status Study
1 Completed Radioactive Holmium Microspheres for the Treatment of Liver Metastases
Conditions: Liver Metastasis;   Liver Tumors
Interventions: Device: holmium-166 poly lactic acid microspheres;   Device: holmium 166 microspheres
2 Active, not recruiting FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Carcinoma;   Liver Metastases
Interventions: Drug: Systemic chemotherapy (FOLFOX);   Device: SIR-Spheres yttrium-90 microspheres
3 Terminated A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
Conditions: Colorectal Neoplasms;   Liver Neoplasms
Intervention: Device: Yttrium-90 Radioactive Resin Microspheres
4 Completed Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: doxorubicin, superabsorbent polymer microspheres, embolotherapy
5 Completed
Has Results
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
6 Completed A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
Condition: Malaria Prophylaxis
Interventions: Drug: azithromycin (AZ) microsphere;   Drug: test chloroquine (CQ) formulation;   Drug: azithromycin (AZ);   Drug: chloroquine (CQ)
7 Completed SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Device: Radioembolisation (SIR-Spheres® microspheres);   Drug: Transarterial Chemoembolisation
8 Not yet recruiting Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Conditions: Colon Cancer;   Rectal Cancer;   Liver Metastases
Interventions: Drug: Tas-102;   Device: SIR-Sphere
9 Recruiting Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Device: SIR-Spheres;   Drug: Regorafenib
10 Unknown  Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients
Condition: Advanced Cancer
Interventions: Drug: DT-LM;   Drug: docetaxel
11 Completed Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Device: Yttrium-90 microspheres (Therasphere MDS Nordion)
12 Withdrawn FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
Conditions: Colorectal Carcinoma;   Liver Metastases
Interventions: Device: SIR-Spheres microspheres;   Drug: FOLFOX6 cycles 1-3;   Drug: FOLFOX6 cycles 4 onwards;   Drug: Bevacizumab cycles 3 onwards
13 Completed Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) Study
Condition: Infertility
Intervention: Drug: Progesterone
14 Completed Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Selective TACE via microsphere loaded with Doxorubicin;   Procedure: Selective traditional TACE
15 Completed Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Octreotide Acetate in Microspheres 20 mg;   Drug: Octreotide Acetate in Microspheres;   Drug: Placebo
16 Completed Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases
Condition: Liver Neoplasms
Intervention: Device: Holmium-166 polylactic microspheres
17 Completed Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
Condition: Menopause
Intervention: Drug: Estradiol + Progesterone
18 Not yet recruiting Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
Conditions: Neuroendocrine Tumors;   Gastrointestinal Neoplasms;   Carcinoid Tumors
Interventions: Drug: Lanreotide;   Device: Y-90 microspheres
19 Completed
Has Results
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
Conditions: Leiomyoma;   Uterine Fibroids;   Uterine Neoplasms;   Menorrhagia;   Leiomyomatosis
Interventions: Procedure: Uterine Fibroid Embolization (UFE);   Device: Contour SE™ Microspheres;   Device: Embosphere® Microspheres
20 Terminated
Has Results
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: Selective internal radiation therapy of the liver with Yttrium-90 glass microspheres (TheraSphere)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years